motor neurone disease glutathione transferase Dysregulation of Homeostasis in Neurodegenerative Diseases Oxytosis/Ferroptosis in Neurodegeneration: the Underlying
Description
10.1016/j.pharmthera.2023.108373 26 CozziA.OrellanaD
Y., Sarmadi, M., Ying, B., Jaklenec, A
The disease is characterized by subnormal ALP levels and elevated PLP and phosphoethanolamine levels
Environmental Health Perspectives, 121 (9), 10681074
Higher dose glutathione IVs may be administered more slowly, which can extend session length and affect overall cost
Methylation values were obtained using the SeSAMe-based harmonization workflow from GDC
